FeatureID,Name,Formula,MW,KEGG.Pathways,name4plot,C,H,N,O,Cl,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,gap_status,Study.File.ID,SampleID1,SampleID2,Batch,RT.Range..min.,Instrument.Name,Software.Revision,Ref..File.ID,Sample.Type,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-017684; ΔMass: -96.2336 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-016129; ΔMass: -205.0627 Da,C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Muramic acid; ΔMass: 162.0529 Da]  Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: Triethyl phosphate; ΔMass: 17.9,C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: RPH; ΔMass: -155.0695 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da],25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.407942392992666,23.195461332925852,1.0834979330156589,0.11569640121109463,0.0530639343556839,0.1631557547566381,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.74444261487047,23.775177722504303,1.0933909939013597,0.12880939743506467,1.0696689310982902e-4,0.00435478375681133,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.2586582595881,26.804838057458902,0.9833513374793652,-0.024221131750665953,0.5149580471270883,0.6009611805835942,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.197292677428234,26.23092937063295,1.0410217362014709,0.05800019196363896,0.40767395132707773,0.5044101431674013,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.225359594187267,23.4907082935275,1.0569326536192993,0.07988345298847026,0.03767266381902063,0.13484961803496479,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.798510239938434,27.717716481872998,0.9970935939599612,-0.00419916277703558,0.9232517294427893,0.9348762159359548,Downregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.556384222891666,25.208479200312652,1.026555007915746,0.037810936283316034,0.5194875826987704,0.6009611805835942,Upregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.913620388919302,23.5661861201706,1.0284793812664745,0.04051287131274404,0.2639031567901919,0.38609376769853154,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.961741097575732,23.6798739698429,1.0312751924697465,0.04442936261395942,0.6597783864539746,0.7210153025619781,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.154752558976366,25.1200462988507,1.0399628908438399,0.05653204937527088,0.41086272910853766,0.506638162583163,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.02464909184,20.8341621915408,0.8325456279158924,-0.2643987531970216,0.05783416741979735,0.1716217163270409,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0545823568341,20.55460603543055,0.8203930818996031,-0.28561276878292846,0.3012446962514177,0.41110723142247246,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.906260379887435,24.4417170815497,1.067032185795393,0.09360369405088073,0.3024899219689556,0.41110723142247246,Upregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.364314091152565,25.581076157410948,1.1973740906573096,0.2598739579785202,0.18398857623688214,0.3167727845587829,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.557753566348502,25.372156208931848,1.2341891407076775,0.303563505873837,0.00512827002361523,0.038996219971240816,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.210697584788768,23.842702562735802,0.9848003131357862,-0.022096874332890055,0.6297065524573525,0.6986106129086129,Downregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2403253242342,21.9967211054223,0.8714911881227778,-0.19844201793266206,0.0038752201252919114,0.03289431036584995,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998228192396265,25.106666922074048,1.0916783115655353,0.12654779519450093,0.039226992519095547,0.136360497804475,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.739819651794633,18.15386847835655,0.9196572612407886,-0.12083179853956583,0.05263407323561624,0.1631557547566381,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.4641933444476,26.7431965791989,1.3739689133753763,0.458349362943104,0.0015534496431131477,0.01829061676568706,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1349158711952,22.144296116189302,0.8810173158990688,-0.1827577201046538,0.008131004345139102,0.0511692514823409,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.422291150294967,23.5052957838124,0.962452524996964,-0.05521271641653738,0.1754740291033232,0.3079231760707354,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.065717896301667,21.1169762206475,0.8424644491735549,-0.24731228702985,0.07923175696641885,0.1977125202626612,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.7379613528228,23.25523540719825,0.9796643891002397,-0.02964049576825881,0.7181081193825982,0.768649453298089,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5283921743242,26.25764155454575,1.0285662087624543,0.04063466306937248,0.14294881560815156,0.27566429096675876,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.4071829786128,21.29325269251035,0.8380800307706107,-0.2548400771168014,0.03255288922643771,0.12776133943709425,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1890698096832,24.61465373844775,0.9771958204262615,-0.03328040183397435,0.20685882962782398,0.3326144176835055,Downregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.040995823119435,27.785641443797502,0.95677302572653,-0.06375137863639399,0.07296200026317368,0.18963697026549714,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.898189288715802,25.684873337374448,1.290814604519832,0.3682818059535615,0.03469511944380523,0.1332179857449022,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.1550346254478,20.43491802646625,0.9223600130597049,-0.11659812549149422,0.14078393127971958,0.2735014289453738,Downregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.346681969244433,23.304879290844298,0.9194449718950334,-0.12116486190297951,0.19074461215557056,0.31945093335945185,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.126188005131233,25.8778375573833,1.2857793811120948,0.3626431208304916,0.061197997459940305,0.1772799132768112,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9070058615956,26.1571257525868,1.1940073380106195,0.2558117030005404,0.10871619526026939,0.2348012501183333,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6758080153392,21.938502541286148,0.8544425370441967,-0.2269446238273235,6.226084042272385e-4,0.009653826478988667,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.611878517628067,26.36947319940235,1.0295798170857653,0.04205567771197294,0.2089257135635347,0.3344644098714481,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.0428689916695,27.8501723661937,1.3234969232198845,0.40435484095301377,9.07523949973455e-4,0.01274024006693504,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.417081003337135,28.27686726411025,1.3849613105560217,0.46984567457873005,0.04015771100217674,0.13698658425976176,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.247283550572032,26.8768854895445,1.3274316736076512,0.4086376036401296,0.0015418122659631571,0.01829061676568706,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.249915318550066,23.885697485838747,0.9459713897848566,-0.08013154392277462,0.6372326324557516,0.7048179116556039,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.513692710912398,20.959039997793653,0.7617676121490207,-0.3925771443256897,0.06861384582655725,0.18478426306978604,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.011204278253935,18.780821928978398,0.8938479527523358,-0.16189865102459183,0.02338958918090644,0.1038404788080138,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.32412765704793,24.0693117363247,1.128736055393546,0.1747081645044968,0.16729700811364454,0.29787028273892807,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.876308209848833,21.6727944535257,0.8063903079361062,-0.3104497958021925,0.05417991863508986,0.1631557547566381,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.132749633445,26.796456676985002,1.3309884225883433,0.4124980222287482,0.11688080834769303,0.2434150125500605,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.213190956215534,21.17617986831185,0.7505772707941996,-0.41392749212448354,0.034241393746918224,0.13295860337899096,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2796698750677,24.2102102571757,1.0866503136237395,0.11988775272465489,0.11154155955499352,0.23533334819406146,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.544396077814234,21.66503594006215,0.8826876762979413,-0.18002503930473637,0.005793026647342705,0.04145989659372721,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.009472405136098,26.79423849464805,1.0301723186571436,0.04288567962093112,0.19169596983393167,0.31945093335945185,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.644551715071298,22.87847824332455,1.1646220578183102,0.2198618486352655,0.026009933542246483,0.1078821107149996,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0160326624329,27.77829231742795,1.261730155625518,0.33540339624141696,0.05422416900727284,0.1631557547566381,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9789785410655,21.62427427609865,1.0307591589252074,0.043707280510257435,0.2983790925832385,0.41110723142247246,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.228510038840568,24.571104227333848,1.014140126154851,0.020257006721571744,0.5386371686562031,0.6143830204984817,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.422939555697535,22.6913979389083,0.8925560275669588,-0.16398536198540364,0.46666571472813734,0.558468806150066,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.159017560899,24.22448520461885,1.0027098636587695,0.003904219296940306,0.9271923018323716,0.9348762159359548,Upregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.685669645715066,22.38814142260415,1.082301990027272,0.11410310427212828,0.009957360377305338,0.058619944156716904,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.948973423729267,25.88570032911965,1.0808688903329537,0.11219153441572287,0.0860491123959123,0.20799951009607942,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.413613221147,17.705557144001098,0.7899465815398339,-0.34017299748780616,0.0698636391880287,0.18478426306978604,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9122366380974,20.249306072789,0.8837769263922229,-0.17824582911724002,0.290994166121775,0.40732195562895174,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5009787108156,26.833306739033,1.3088793036440103,0.38833206744169335,0.11483739098965043,0.24089452707599085,Upregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.053444672647533,24.09382794992685,0.9247847358634306,-0.11281050941454725,0.05157300883426005,0.1631557547566381,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.138271564927766,21.721300091426798,1.0275816556102146,0.03925304058647852,0.7422317525080069,0.7875424118180888,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.66178940283317,23.22284733402325,1.0247578830257746,0.03528308805363736,0.22076704367433844,0.34789626136429336,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.828976523187333,24.854760015604597,1.1386131635261596,0.18727768396002928,0.06479908996828518,0.1832631869989366,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.803799803649532,24.540031592252852,0.9510239491465152,-0.0724464226975663,0.004185323742092921,0.03471916286054355,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.068228144579766,23.869376938693847,0.9521764681982466,-0.07069911988220455,0.01580161563759978,0.08010541260727666,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.554467561037935,26.4459714433321,1.2269368922448398,0.2950610455885631,0.32467163548520034,0.4266785556735949,Upregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.333428878772068,23.69964293394945,0.8670570764853903,-0.20580112883113744,0.0020967957948137377,0.02125917958630595,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.9579323568517,26.76554990452395,1.490458331875372,0.5757560430667182,0.0011777090647981236,0.014822889953493625,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00392183828807,19.58086570508265,0.8511968455957787,-0.23243529044365382,0.030579889431855554,0.12265560046843162,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.405965885807632,23.62370596640795,0.8619913658522669,-0.214254676274267,0.04297702680767192,0.14260558895272954,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.21594275614933,22.712716438859097,0.97832410587087,-0.031615604687821514,0.48064234856264865,0.5695923935888532,Downregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233860585341567,25.45120868746415,1.2578523302617937,0.33096256219818854,0.06847215260130089,0.18478426306978604,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7506624331551,20.1122132528124,0.8840275887308836,-0.17783670094469234,0.29647391138867574,0.41110723142247246,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.219685376707634,25.1186094782206,1.0371154326545244,0.05257647742031364,0.4159695719309589,0.5112083964808081,Upregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.41917653977377,24.998310611167753,1.0674291031843957,0.09414025169033163,0.23820432001080935,0.36076587885454525,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.752938758383564,25.3507347353985,0.9843822086963131,-0.022709511509767515,0.7156896378320634,0.7683138759079504,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.527140318640498,25.905829797250497,1.3266576351951,0.4077961086631509,0.004698452896183274,0.03728120232841076,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.4451464689765,23.19597692506715,0.989372233428396,-0.015414683825504467,0.8504000079870024,0.881806826463795,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4664053587124,20.3809892533587,0.9958265213721402,-0.006033656363747996,0.6585134682064395,0.7210153025619781,Downregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.78128734231767,20.5439402227232,0.7968547089967136,-0.3276113941571619,0.0796266862427704,0.1977125202626612,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.263708096473167,20.8804301159577,0.7950297817527768,-0.3309191902359306,0.2871589089889999,0.40732195562895174,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.6741883835944,22.9582799877045,1.0125292953954483,0.017963649933374855,0.6786484378145634,0.7350346581671088,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.403340594236433,18.433968672103802,0.9034779666086179,-0.14643867681030764,0.11075631107483308,0.23533334819406146,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6284653770252,23.33994252562805,0.9107038670583565,-0.1349460847456444,0.36541724396475933,0.4583412166568287,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29688379223497,28.94670598999225,1.060439946563666,0.08466292237912519,0.04774585519405655,0.15287050127921614,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3257870660719,22.540690307545752,1.1663530303051872,0.22200452780373411,0.044568359535347477,0.1452451002714449,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.643191339414667,23.04876049164805,0.898825742341248,-0.15388665103683885,0.10448624478133764,0.22836813979154633,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1673021379854,26.40253124807905,1.0924898069851325,0.12761981933172986,0.15540460350298596,0.28503859436477325,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.485478616356,25.673434932697198,1.0073750357672533,0.010600884449970281,0.8316280920238469,0.8687020052121168,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.220107095375333,23.816315432613152,1.1778530806130265,0.23615959596816635,0.22202548380507747,0.34789626136429336,Upregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.062413030387233,27.16373653537035,1.2896782764719597,0.3670112153950456,0.09713130477247123,0.22297437888020127,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.506857078826467,24.85137777406935,1.0140581345920747,0.02014036248282457,0.591494132346158,0.6663436984763816,Upregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7424476581726,23.175101846598153,1.0190240819690344,0.027188146230682893,0.9147248182510554,0.9300126982218252,Upregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00946532151083,23.2388163517483,1.009967681866256,0.014309128662951698,0.6082730485161668,0.6810419101484689,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7509758389579,22.8920390434157,0.8889775357088799,-0.16978113199753495,0.11027086142420518,0.23533334819406146,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.056750236860434,26.966520925332148,1.1695716286253224,0.22598022004696883,0.005459700456655547,0.04066919727916887,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.864338447523732,25.2735521178166,0.977158266355593,-0.033335846312425595,0.8569387637754478,0.8860698265666811,Downregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.485278164122967,24.5241399665019,1.0906754093721684,0.1252218120517687,0.312571448547002,0.4163816741593275,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.369106172406365,25.185434957443,1.0777235026293521,0.10798709223557346,0.2630839837291661,0.38609376769853154,Upregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.2162667315832,24.6165150506719,1.016528076913139,0.023650063548550194,0.7153437452140229,0.7683138759079504,Upregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.3287090280501,25.019118833451,1.0724604950650451,0.10092450588478462,0.16955767390321458,0.29897850712402574,Upregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.847988439218298,21.51541754378945,1.032014076874468,0.045462649538762535,0.6202017621850209,0.6922741382187542,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.174641952957668,20.8825544156633,0.9862057862445429,-0.020039377475405597,0.895372905371785,0.912880196817602,Downregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.488864726080934,25.41184822176465,1.0376899258502876,0.05337541357337103,0.25984604035635295,0.38609376769853154,Upregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9199872717622,21.2625839820125,0.9700089565929365,-0.04393002637877585,0.6916738734727785,0.7469259284543319,Downregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.6835499746075,24.503147565876702,0.9926913912740921,-0.01058281366718819,0.7488757413167455,0.7922888277698902,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.547712441244734,19.23183005275025,0.9359596649866894,-0.09548173642219474,0.2644477860948846,0.38609376769853154,Downregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.767628573607734,25.6226006090616,1.03451973744329,0.04896117041775464,0.13786374832833953,0.2705390760206663,Upregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.585221854400533,26.8797459445161,1.0110784890842208,0.015894996664528066,0.34721525012563836,0.4446791799854667,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.323364623036635,28.0413150639814,1.065263330335869,0.0912101050144868,0.3371007427105499,0.43787107149235127,Upregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.542080512256565,25.9822482131693,1.0172330402255805,0.024650227340679693,0.45821370596845673,0.5538013333724726,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.838752491447302,25.77234966549715,1.0375863149476332,0.053231356668919316,0.3641194792766456,0.45828831012405397,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.631676846629134,27.21336672975825,1.2580331577021922,0.3311699475129946,0.12786828663698702,0.25643914627747394,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.329986490048935,23.48628729181045,0.8290257145043164,-0.27051124333220006,9.408174671852708e-5,0.00435478375681133,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.706802019198832,29.76845110550505,1.0020752515288038,0.002990852775577138,0.9419669717184085,0.9419669717184085,Upregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5565973675619,26.229203061489898,1.0681122742248252,0.09506330334941454,0.06854685674060164,0.18478426306978604,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.379417144279667,29.42937348375365,1.2071401588310282,0.2715931944948372,0.01185504755482939,0.06601796533722441,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.1527692666301,24.5882840776545,1.0620018622607446,0.08678629596502836,0.010921361273766446,0.062285888514449265,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.606819135752566,27.97147731735895,1.2945671059501236,0.37246975157419643,0.003421486809533368,0.029734349654278076,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.9551314222807,28.89238278088895,0.9978329008258804,-0.003129855811818517,0.934429821062693,0.9369969359557224,Downregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.402744852134898,23.3908462708306,1.0441062657820495,0.06226855224770119,0.4602882598241867,0.5544726562238553,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9980105477586,26.0075928664766,1.238574140503646,0.30868023026011115,0.023775352205683824,0.1038404788080138,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.872479127760766,26.504660159882448,1.0244344977147304,0.03482774145680461,0.4216573871939104,0.5153997189799443,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.558540571265333,29.603136651080852,1.0015087375409486,0.002175007822620554,0.9257981621951988,0.9348762159359548,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5673811415301,25.3584226069324,1.075996626636048,0.10567355489911547,0.25373271775615974,0.3811211604156309,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.265576557763268,21.4209189865228,1.0073048773607232,0.010500404781156335,0.42287430310108665,0.5153997189799443,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29578748337073,27.7741006097023,1.0175233312694485,0.02506187510167089,0.6777000608170223,0.7350346581671088,Upregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.605506312451666,25.1723864511524,1.113551101365371,0.15516776557498035,0.12131009321766668,0.24610504155004523,Upregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.188836468469432,17.2893703577749,0.5923281791808092,-0.7555313729324573,0.001726483695623905,0.01853431026184486,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.9690485682693,23.870214967716002,0.9191794187208772,-0.12158159982081283,0.1067941461764898,0.2320229961572546,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.162121903180267,25.184030448079497,1.1900522340481752,0.2510248980277,0.0034018108657012853,0.029734349654278076,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.189612752017766,24.85355773281085,1.1729123143340214,0.23009516306464306,0.003332077551351169,0.029734349654278076,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.672776162969733,22.460234843147248,0.8420658841777847,-0.24799497910397306,0.13277298568299656,0.26213786818925816,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.954230328944,17.82479886585455,0.6376422693848462,-0.6491808259563931,6.347721520430904e-4,0.009653826478988667,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9479141808808,24.175823595902,1.1540921634081982,0.20675843921971712,0.27645948381339824,0.3972744550861825,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.504502543750032,22.89218541652145,1.0645298755434232,0.09021643893396049,0.0821943460588868,0.20116347669035306,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.563278219812368,24.4783832917583,1.135188399566608,0.1829317517580735,0.09192034726846164,0.21370017040120065,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.620451402682633,23.359515597832,0.9117526943879726,-0.1332855369046173,0.36004508361309384,0.4547282197881635,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.555228991257366,25.8135268852834,1.0512435821500195,0.0720969928432227,0.322330849419822,0.4262708697037501,Upregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.840150738786633,25.71805829072145,1.1775586440915866,0.23579890988760116,0.15174866352476818,0.2811586913022354,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.567895788320666,26.70814365438745,1.1834574168943763,0.24300779602558129,0.002448588539397647,0.024154995050814625,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.561836777165034,21.802780742548848,0.8876689858479452,-0.17190630288953632,0.08864143180316311,0.21009170524775675,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3981130128564,25.8095641419603,1.2061607547568993,0.270422199638464,0.018406176981155816,0.08839808681739306,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.894090157072235,25.79258693167405,1.0794546585419948,0.11030264561107549,0.01959468202779949,0.09288388233956903,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.15164285610477,21.2177934828878,1.0529063875534124,0.0743771740502197,0.024466523773942973,0.1038404788080138,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.835045670648267,28.3840757006102,1.0197244163511785,0.0281793121156924,0.5495521700134897,0.6248801933175194,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.787765588756834,27.986085451387098,1.3462767478253417,0.4289750085181401,0.06975329339979863,0.18478426306978604,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.8212354942801,29.45261770847615,1.2905794568334452,0.3680189662677932,4.2431253544651936e-4,0.007743703771898978,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.7995954892184,29.8759837974137,1.0746913137279495,0.10392233041395624,0.03806532177341625,0.13489167424560128,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.64397230403607,27.79214852810035,1.043093282449117,0.060868181931496484,0.15062112074969433,0.2810411197509084,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.313524149789068,25.38270203987045,1.0887544018135973,0.12267855162488413,0.05397784199684272,0.1631557547566381,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.868546812958332,27.1547381226947,1.0106515365988584,0.015285654927837707,0.20559206896820206,0.3326144176835055,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.2252185950105,24.771429813869148,1.288486250049612,0.3656771417058127,0.15853294549094663,0.2878214794916698,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.001326773269966,20.05241985490835,0.8020542284318801,-0.3182283115177946,0.14797350990388108,0.2784870570346731,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.520538863658167,26.328663066086698,1.2234202513649894,0.29092006242259166,2.285118578916879e-4,0.005957630580747578,Upregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.177561234784534,24.60238117152155,1.061474109476137,0.08606918274973512,0.22815390092283916,0.352865143376425,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.263921101878132,25.14897656770625,0.9954502496382741,-0.006578879789079088,0.8494599335235238,0.881806826463795,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.902505385890766,24.732515460142302,0.9548310131271794,-0.06668266864555995,4.4676149453109755e-4,0.007765140262088123,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.841374216941965,21.94824863270125,0.8835360089592956,-0.17863916114231426,0.01631020822730042,0.0815510411365021,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.9016460590687,22.8380517370103,0.9171302042779265,-0.12480152820844448,3.265949034051934e-4,0.006376896297352494,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.337845324658733,21.0273191785478,1.033901027512148,0.048098087053719533,0.07646377161949026,0.19516976672107655,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.283736483225233,22.385483154294853,0.961421426944188,-0.05675913809176078,0.7689004216505557,0.8087857461165788,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6170812368189,21.450791440752,0.837362822190735,-0.25607522915179054,0.1935880456040078,0.3197268626491531,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.5790576791569,27.2432923648851,1.0249909042580199,0.03561110735016368,0.18285503104834375,0.3167727845587829,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.117755108707733,27.6868628210534,1.0209865348390479,0.029963839527145025,0.18315585434356604,0.3167727845587829,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.0818105806586,28.190642080362352,0.9371324909042478,-0.09367506572434359,0.09985736936626542,0.22575899697932744,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.156998688789635,28.9879493951799,1.1082291871507244,0.14825626854749177,0.13286439894524044,0.26213786818925816,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.871122848929566,29.6510956400709,0.9926341165689876,-0.010666054357663551,0.3587574806684933,0.4546752793194446,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.761280511048,21.30920568715985,1.0263916850321575,0.03758138807777984,0.19254576805227233,0.31945093335945185,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.703912334952065,22.152118064285048,1.0699484090689537,0.09754123422008171,0.32497709171851885,0.4266785556735949,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.321758138172733,22.599501722564348,1.112083982542488,0.1532657418586486,0.14397443250661904,0.27566429096675876,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.034094390238234,23.75555938845675,1.1857565870325453,0.24580788279887933,0.4026846760102259,0.5016314446870639,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.309967127957567,26.2376608624531,1.3587625855905991,0.4422933983326603,0.0019959097638748728,0.020814487537552245,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.6267392530669,24.05589131804685,1.2256692774011273,0.293569748833092,0.1880898615017901,0.31931534627048086,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.491223159638867,24.5900156585921,0.8338079273783915,-0.26221300634009476,4.101239591490493e-5,0.00435478375681133,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9515697096492,23.26171572056915,0.8630931693837852,-0.21241179069430569,3.319480264375271e-4,0.006376896297352494,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0781439411166,27.96814816486275,1.2667798633551377,0.3411658396806837,0.20596407845431952,0.3326144176835055,Upregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.6198646708862,30.727324357162452,1.0035094761989076,0.005054240218837001,0.6748919246754161,0.7350346581671088,Upregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.966930126672267,22.1206381530032,0.8518772933532756,-0.23128245906055667,0.012815028724631685,0.06981321618642634,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.3570908717408,26.6354190323964,1.0105598968418026,0.015154834152775827,0.735929397311269,0.7831318659434787,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.298632823128234,29.0994283603075,1.3662580411597294,0.45022998695454547,0.06418417279867913,0.1832631869989366,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.677622124839033,18.1545023988405,0.9225963525300193,-0.11622850614437774,0.0028370118431134727,0.02655152109580558,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1262680973742,21.87396901331925,0.8705617932813975,-0.19998138954789202,0.0910250593755248,0.2129752991799138,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.5817511477294,23.01939038202365,1.0666136507854926,0.09303769721990336,0.1408719688814528,0.2735014289453738,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.82234069831477,24.23687889976985,1.1106452435527021,0.15139807226469676,0.3096960885094589,0.4155848246542371,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9331233558923,24.44429654588755,1.0658947831284822,0.09206503345303119,0.19499755245941497,0.3206040839985877,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.12158739994147,27.2542267511263,1.043360280286311,0.06123741752305718,0.0027066224950929767,0.025997821334445694,Upregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998853634013734,20.973794418627747,0.9119495585470807,-0.13297406616237287,0.2888314746675599,0.40732195562895174,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.452145215237465,24.2627225145486,0.9532682730421955,-0.06904581388778175,0.5373083501078499,0.6143830204984817,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.757380008008365,29.6151914158256,1.1068046051953482,0.14640055184210007,0.0545342522748215,0.1631557547566381,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.296029876742733,23.11277504455395,0.846744935029798,-0.2400006429042718,0.14801777825952486,0.2784870570346731,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.588377692244666,20.4208818775815,0.9459201691156917,-0.08020966235938978,0.20048117940024077,0.3281418407223672,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.57394168448643,22.4472009112346,0.8447072390596471,-0.2434766800493735,0.02425567069083864,0.1038404788080138,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.287566358448235,24.29453240472635,0.9241833980922556,-0.11374892153212687,0.516153794779399,0.6009611805835942,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.778973971553768,28.338934708773202,0.9516424150759473,-0.07150852020708945,0.4888427059307119,0.5774355587854688,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.288964095394434,24.438949190562703,1.1479632865673217,0.19907650339494481,0.10176734678025677,0.22649439984630318,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.044612508293735,20.36909560420705,0.7820848015197249,-0.3546030473305519,0.03575500807031034,0.13454204067694098,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3375771539039,25.43053115526125,1.315083629808675,0.39515454740644257,0.013445320461520017,0.07216973483021773,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.854403421427865,24.2489201335533,0.8705596657977267,-0.19998491521822986,0.01766101416415839,0.08595026893223749,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.135976787515034,23.49877225663205,0.934866086775821,-0.09716837136385388,0.11132673989012966,0.23533334819406146,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.343184645236466,25.38885673095195,0.9637732519003892,-0.05323433311860305,0.3390897184883403,0.43889272073845464,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.357741114146734,24.48199834214655,1.005101344472688,0.007340975828858518,0.6226181099970008,0.6928524699661747,Upregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.7260441492229,25.165850306912752,1.017787162193661,0.025435899182368986,0.4378581384700547,0.530957543327475,Upregulated
Feature0162,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.709516861524133,21.87088056584875,0.8851197167640497,-0.17605549494481174,0.03967849631587566,0.13662878448391147,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1127693037458,20.118277330338053,0.7420222222581515,-0.4304657012197765,3.2778098473129315e-4,0.006376896297352494,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.150812261294234,21.033023813968448,0.8042971516070032,-0.314199484095673,2.8368894145498805e-6,0.0010354646363107064,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2056250022279,19.5950751039009,0.9240508167923467,-0.11395590220879745,0.16196658939580091,0.2912207149234844,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.984226277562833,19.022825417552802,0.951892014899299,-0.07113017514145831,0.006312960545579421,0.043476049040311104,Downregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.027805077287,26.44326393359195,1.466804406871887,0.552676505606358,0.0663271401936459,0.18478426306978604,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2589416455298,22.4016110328551,0.8868784506978592,-0.17319170241466192,0.021093252278605312,0.09623796352113674,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1330242206675,22.2332198584339,1.1043159544610515,0.14315299885520436,0.34177714454324015,0.4392558371770516,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.487271159626534,21.84388062119455,0.9300305885999693,-0.10464992781103753,0.21982299953633433,0.34789626136429336,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.885192909423132,23.99723053894885,0.8925816757125791,-0.16394390585299562,5.227347762558326e-5,0.00435478375681133,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.533304718063835,25.6015639757575,0.9298398516964448,-0.10494583571927897,0.4959895829491814,0.5839877347627459,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5201462788572,24.9931704721843,1.2179820812454856,0.2844929087052996,0.1914906300096632,0.31945093335945185,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.28494784883633,20.6783209240109,0.9714997222857374,-0.041714511487495595,0.40405382119999117,0.5016314446870639,Downregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.483650686592433,25.9755965475957,1.3331996639351917,0.4148928588951122,0.03696022260576774,0.13484961803496479,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.744220493661132,25.94430897883735,1.0077721710480798,0.01116952291537886,0.0683074771554965,0.18478426306978604,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.033030997983367,27.165683950326347,1.0049070691463666,0.007062091373624817,0.35541280479371323,0.45200583188050636,Upregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.177444834329734,25.859769253065352,1.1660391648471395,0.2216162464988094,0.27204407614668796,0.3956019434005622,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.834202667511068,23.66085219600155,1.1929318557765183,0.2545116338620064,0.04345479935215267,0.14289190777960112,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.990975576346532,20.90917004649325,0.9094511877958291,-0.13693188748304172,0.29365658885549584,0.4091017363826564,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.059242391155134,27.200045489939647,0.9360204620550817,-0.09538802642192921,0.0871365225637221,0.20916456202180134,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.412497504333768,20.79231747929835,0.7318018233394263,-0.45047508462239944,4.7364746616210057e-4,0.00785824205223485,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.742370708521133,19.93921060735955,0.7456037022553935,-0.4235190712521494,1.409319647076518e-4,0.00514401671182929,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2163505203505,20.5850988897583,0.8163393379682514,-0.2927591149468782,0.03708555284595014,0.13484961803496479,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7978891841521,20.9686541264686,0.812805031325968,-0.2990187623558302,0.30813373067283334,0.41501406529735857,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.690595006397167,23.84506713088615,0.9281632879638846,-0.10754945977948377,0.2573396540965346,0.3849548104312915,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7047207876297,21.4274038558941,0.8023826208967447,-0.3176377364666923,0.26433295411751917,0.38609376769853154,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.699197907164532,23.56752427054215,0.9541817657044598,-0.06766397802553602,0.3042217186436702,0.4112626937219986,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.679578733382233,23.745539041940702,0.9246856924125718,-0.1129650287767803,0.1861148912438937,0.3185094523998049,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.024029563661834,18.92025460421065,0.7001270687496577,-0.5143113088038737,0.03014253671774932,0.12224473224420557,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.401371012909834,21.5976569857402,0.8851001435252841,-0.17608739856891606,0.0010265773477536107,0.013877804886298813,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.456191243790133,20.98512376223815,0.8243622764013186,-0.27864960759141816,0.001720838278632791,0.01853431026184486,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0373156234092,26.390774122279247,1.0135750744808834,0.019452951725362547,0.8900146256777617,0.9099589310150784,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.089018858301568,20.1855185919819,0.7737170455361465,-0.3701220370923535,0.027189751166557304,0.11150853006509455,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.4009417910584,20.6836989418038,0.7834454962060883,-0.3520951840546293,0.014614869607078163,0.07620610580833613,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.400816448575434,21.7317442348762,0.7651802642443488,-0.38612843114059636,0.025964808216622403,0.1078821107149996,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.932855803236833,20.61103775325465,0.8987558257068675,-0.15399887780144322,0.3006430550524622,0.41110723142247246,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5078685143157,22.18348201866365,0.9051575417791101,-0.14375918118548128,0.15091523142788504,0.2810411197509084,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.615391696269732,24.718747822343047,1.0467219066388638,0.06587819756549451,0.3323933114239026,0.4348514647660375,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.510191620200033,25.33445055674775,1.0336292326604417,0.047718777406351214,0.34069698628679684,0.4392558371770516,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.189322601660834,25.1478931102284,1.0396278359817215,0.056067167525249956,0.2639136141210221,0.38609376769853154,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.916636149877867,27.4859289256474,1.0211502199828977,0.030195114680728555,0.31175751379696637,0.4163816741593275,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.413112124171565,24.55513984692665,1.0487772713297718,0.06870832551676247,0.2220817230078914,0.34789626136429336,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.87206979706057,21.05290077363665,0.8464474788553675,-0.2405075416461138,0.11737271838030315,0.2434150125500605,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.951092444429367,18.517409133205447,0.9281401098602886,-0.10758548722538089,3.1407085125059893e-4,0.006376896297352494,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.3482039468935,23.14888757271345,0.9507431276329084,-0.07287248939411073,0.037684002848127146,0.13484961803496479,Downregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.863630435559966,23.379498908793998,0.8703030279126402,-0.20041027927265911,0.03503815515482359,0.1332179857449022,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.032168307553732,20.7392919469022,0.7398390206337928,-0.4347167017108214,0.02051600674361758,0.09478914508127109,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.262904731259933,20.5949919851407,0.7286933944323775,-0.4566161820884688,0.02406784487117971,0.1038404788080138,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.613945178006098,25.56056414904825,1.3031832156699579,0.3820399279250769,0.04713791263546173,0.15225962930923478,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.062944781159565,23.41814062424495,1.1672334684505603,0.2230931558079556,0.4236162073807762,0.5153997189799443,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.382246889058866,19.621928776688698,0.9626970413758306,-0.05484623832541587,0.12136686980550176,0.24610504155004523,Downregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.7623996634916,20.09428163075835,1.0167936066934147,0.024026864231371903,0.8748932156632016,0.8995380949776579,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.748550628520334,20.312506721971452,1.0285568345778584,0.04062151452225688,0.15256909300047922,0.2812511057837117,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.827245017364934,24.176629061167752,1.219364013507352,0.2861288741834642,0.189007155384108,0.3193870912740714,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9638813099357,23.73140777184555,1.132014030273974,0.1788918391602965,0.08767719997078248,0.20916456202180134,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1283951348602,27.7849217271816,1.024200716225847,0.03449847307966012,0.16391505292911618,0.2932793839172912,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.780710366775267,21.4570940086101,0.832292582451987,-0.2648373152584081,0.07461829130650785,0.1918005375132068,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4170275175503,19.615105014052652,0.960722857291135,-0.057807782594478815,0.20287949389041707,0.33058488959822424,Downregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.327093753602,26.077831273975,1.02964167652541,0.04214235542693584,0.10424626023026268,0.22836813979154633,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233125388957568,18.779517136264552,0.9281570086306915,-0.10755922012404759,0.01691725286708887,0.0834432067092897,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.588858503773366,28.50653732988025,1.4552423932404783,0.5412594764328169,0.014279801749837314,0.07553808172015392,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.228429364978602,25.015262412044102,1.236638888798402,0.30642428010642203,0.007046440802971743,0.047628720242309006,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9070926521018,24.2957886302379,0.9029510896763526,-0.14728025180186108,2.1627478484329652e-4,0.005957630580747578,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.336937995903735,20.997870413923202,0.9400514259283839,-0.0891884126689338,0.5168491915312386,0.6009611805835942,Downregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.7541324729329,25.70665333472575,1.1816905761105707,0.2408523174521135,0.020152923831731524,0.09430534869976931,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7908990243229,23.15747865564335,0.8643785576071619,-0.21026481077127598,9.796866219767405e-5,0.00435478375681133,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.868456251191,20.995664092875302,1.0060956996604404,0.00876754058970593,0.8024582612498459,0.8416588084948097,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.120432812705765,22.5592668579716,0.9757285705124958,-0.0354482221371483,0.8728772174328334,0.8995380949776579,Downregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.085988905457732,25.7098879998663,1.0248704205666308,0.03544151419557306,0.2903290954280445,0.40732195562895174,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.839924414902033,22.445092221945202,1.077023686606817,0.10704997892057466,0.6003635491973706,0.6742544475601239,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.904560927185265,25.846475545386802,1.0378209686553181,0.053557590217891075,0.46462163389829536,0.5578516328055191,Upregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.863602612978767,23.9298468095001,1.146966190518501,0.19782286520710257,0.007208807058231365,0.04784026502280815,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.99529426068173,20.1236549643953,1.00641954562109,0.009231846106465777,0.5739299659821645,0.6485586302894428,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1455579858692,18.87525600098105,0.9369438173030906,-0.09396555386344832,0.004439894004514608,0.03601247359217404,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2502223786611,21.1078015317839,0.9486557559994173,-0.07604343146679438,0.0928647548078953,0.2145293386384923,Downregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0487066532288,22.79879585188835,0.9101785640077975,-0.13577848568938433,0.2809506765443726,0.402145086034102,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.535680712697165,23.435514072668752,0.9177556038682712,-0.12381807635711141,0.18674252825632395,0.3185094523998049,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1917360610915,25.1415154177053,1.039260487722556,0.05555730702793479,0.054382904733630465,0.1631557547566381,Upregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.204879190669335,19.99105386823755,0.8615021739167656,-0.2150736579322288,0.22624436917850274,0.3514008287240574,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.294101278329766,19.80820950831475,0.9760574876733341,-0.03496197298160529,0.5709701497951106,0.6472177163826565,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.374970759917467,19.795477118161152,0.9715585534534203,-0.04162714876147598,0.1774381790361931,0.30988007343641377,Downregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.153432946019766,27.4168428567798,1.1841372690045493,0.2438363325151111,0.015667514568924092,0.08010541260727666,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.458464449390632,24.657522248384602,1.0979166587256877,0.13476854559401427,0.15928750371867753,0.2878214794916698,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.948449807332565,21.5134167510648,0.9801793265544234,-0.028882376411414175,0.5287743555561017,0.6088411349463001,Downregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.772596146786732,24.34477066098255,0.9445990819988773,-0.08222596146993093,0.2744267569693124,0.3959121197383361,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.776434596386334,24.795220305298848,1.0886348431915156,0.12252011726893074,0.23082413483237008,0.35399635797922124,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.652267932473134,19.40216530061835,0.7279742703238677,-0.45804063448006915,1.0737822962000538e-4,0.00435478375681133,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.892884326500965,28.161045867405548,1.4156341234986158,0.5014484430900296,0.06029771410755776,0.17606932519406865,Upregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.656060688508035,26.6320873876476,1.038042734268116,0.05386583796131443,0.28256352141740154,0.4028737707709045,Upregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.311871832884066,20.3835898722342,1.0035308434367938,0.005084958493737032,0.7649512854866423,0.8069572809324405,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2313759165343,22.295625718001098,1.0501262756427385,0.07056281959606006,0.47043490216706224,0.5604777777893927,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.26382700578173,26.6579219953884,1.4596021954735647,0.5455752260791826,0.07818358986666876,0.19680696759540756,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.361822214297067,26.18181042867795,0.8916956937342028,-0.16537664488052534,0.008606280228896127,0.05324224209401841,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.393299284277134,17.76783581881685,0.8712585232599185,-0.1988272303858768,2.5893926962388983e-5,0.00435478375681133,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.14027449491263,25.0979950423935,1.039673142394578,0.05613003801666858,0.1586702569087888,0.2878214794916698,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.371172789153334,26.257573837926,1.0349373304946952,0.04954340953919666,0.1001998835908248,0.22575899697932744,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.853754779498466,25.83561270770635,1.039505416260798,0.055897275264331144,0.0364190455553288,0.13484961803496479,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.166550954669468,22.5466623186867,1.0652024681287422,0.09112767646342863,0.2995281657068398,0.41110723142247246,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.554678366624834,27.1741437487977,1.0233279188555882,0.03326852152492657,0.10252408865188112,0.22679571126022186,Upregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.7885600300926,27.4621108219501,1.5438074119261433,0.6264927894007919,0.04089263200011474,0.1378957325514585,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4123003984983,19.322533271397,0.9466122335147746,-0.07915452806456894,0.009519238689755547,0.05695937904525861,Downregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9172968734495,22.810606560307498,0.9953445507237981,-0.006732076190694564,0.6504358685980356,0.7150876266213343,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.526777268834433,25.02861032329365,1.0638350521747264,0.08927447804100565,0.12079183955450531,0.24610504155004523,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6141363416845,26.2384143201946,1.0243724000755845,0.03474028767463438,0.06434336588195118,0.1832631869989366,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1963520003667,24.91311887967435,0.9887589631749775,-0.01630922710271204,0.9337022688396042,0.9369969359557224,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.223281103430168,23.089430953345747,1.1417252638311712,0.19121553319366186,0.31738002531651077,0.42124985178373253,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5144914430735,22.98509408394345,0.937612519407896,-0.09293626151041164,0.2356116129409412,0.3583259946810147,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.4285277741955,27.1820436854281,1.474998112626755,0.5607131084366735,7.836814711193056e-4,0.011441749478341862,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.061523660293666,23.37360129647795,1.0594735729221532,0.0833476021606223,0.02137579411919256,0.09632302288278127,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.735328700917034,25.88049784778915,1.1383384066378268,0.18692950755841772,0.009374041374741049,0.05695937904525861,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.920898765996498,24.08276103737625,1.0506900834579573,0.0713371878601261,0.23179487549872296,0.35399635797922124,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.344425896994334,19.02939365664865,0.9353615458600891,-0.09640397630510733,0.001646760684652465,0.01853431026184486,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5677109691208,27.43293775227475,1.072952435413818,0.10158612202771326,0.004853568644767632,0.03769260756042948,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.8544979755182,23.29246326185525,1.173158006340743,0.2303973352867247,0.14425172486205734,0.27566429096675876,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8057919080478,23.690896561367097,0.9951736389562464,-0.0069798243010717595,0.6500407177612291,0.7150876266213343,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.949233537273432,23.154134106469797,1.0089284275600565,0.01282383463597587,0.8330019228061394,0.8687020052121168,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.689214271817967,27.5507597914207,1.2142668080684136,0.28008545650708927,0.06527182002701852,0.1832631869989366,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.943078066548534,17.1027366778941,0.9028488727022521,-0.1474435787758995,0.12359054063526423,0.24922954327000799,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.450776231692533,19.5165338517821,0.909828793185923,-0.13633300282843197,0.3029803979524523,0.41110723142247246,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.710330624422134,25.455690157971148,1.0301638834735924,0.042873866599866126,0.1474879742085275,0.2784870570346731,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.4026006492414,24.37657836937555,0.8582516323210925,-0.22052739881982514,1.7144157415141593e-4,0.005688743142296983,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.702428780805732,20.011622492148298,1.0156931774646882,0.022464655848387124,0.3363969240090693,0.43787107149235127,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.714763838537966,30.144424719948,1.3881995191883971,0.4732149343840151,0.22123981610809929,0.34789626136429336,Upregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.715623610091935,20.10751083188925,0.9706447273976134,-0.04298475373437772,0.04117982150166843,0.1378957325514585,Downregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.466324749141865,26.2093577454807,1.2806089059336183,0.35682994826480313,0.0056590321786331955,0.04131093490402232,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.135188750022433,23.297286121697553,0.8914144965445316,-0.16583167205341143,0.08061471070737442,0.19881330681210582,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.178076009583133,21.043725067020297,0.9488525992032544,-0.07574410765696926,0.2315661109185311,0.35399635797922124,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.102437461856866,23.7730456668752,0.8459424809375378,-0.2413685228982416,0.35250526386450465,0.4498755989879168,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2589859918705,23.3552707894046,1.049251335974356,0.06936030015720457,0.5196443343144437,0.6009611805835942,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.322873501723432,25.45546796330295,0.9670474601352436,-0.048341399785501664,0.09821532465194355,0.22405370936224622,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0102114360189,20.41233239890105,0.784781486652357,-0.349637086752576,0.0061484340509440506,0.04315727747297266,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.335986760269634,22.8760332939877,0.7797942329647221,-0.35883460968754316,0.059260915209463326,0.17443737138269447,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.563826621920168,24.7255116653724,0.9672069847387817,-0.04810343176060604,0.4714155555653247,0.5604777777893927,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.23635475283143,24.96225341869065,0.9891386320716534,-0.01575535976149259,0.7223523688669677,0.770931621743986,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.499092492767666,23.24042118159305,0.9486237577352636,-0.07609209455168171,0.07325702139023314,0.18963697026549714,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.105446800116166,27.0395591869147,1.2811649733359767,0.35745626091704286,0.010615985838246484,0.06150531477714233,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4927288422862,20.26062524904955,0.9886738562236909,-0.016433411727785185,0.5202842001764816,0.6009611805835942,Downregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.521174649017933,26.98653978589045,1.0175469278050906,0.02509533105219913,0.00764744665639721,0.04897049174710494,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.1453306316713,17.34418727220895,0.9558485113484779,-0.06514610559776356,0.2733436063379194,0.3959121197383361,Downregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.640585695144335,26.24217010554615,1.0234621945674096,0.03345781196810795,0.22487666873197007,0.3507691627656798,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7950302393238,20.57939225006545,0.7978045406084752,-0.32589276051381727,1.8892193867353863e-4,0.005746375634653467,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.577453625105935,22.6292312235979,0.8847335452261689,-0.17668507004399023,3.202979491620488e-4,0.006376896297352494,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2313848022398,24.81900568301775,1.1163949481238455,0.15884750109206972,0.3825207552674977,0.4781509440843721,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3713905929201,27.390743978435097,1.2816547364732123,0.3580076683025855,0.001071345012557753,0.013965747485127853,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.402632454270133,18.86412925686755,0.924592907270621,-0.11310979946119293,0.08266992192754236,0.20116347669035306,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.399859400605,21.68415688277695,0.8887000751422071,-0.1702314847323484,0.03888334732313331,0.136360497804475,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.548606790391165,23.1697222617682,1.0275456251976383,0.03920245403834996,0.8804550490581002,0.9027137441185578,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.582339337728765,26.370300553983498,1.16773998298423,0.22371906957744767,0.29126309703878467,0.40732195562895174,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.58893607761833,21.21647814887515,0.8291270135077009,-0.27033497058296196,9.691550554526756e-5,0.00435478375681133,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.778873307002566,25.4821025298737,1.0283801936495798,0.04037372959897058,0.09007563643641214,0.21211359547929312,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.392675539652867,25.2024555841943,1.0331976721137068,0.04711629805190896,0.07053498012845955,0.1852177535747319,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.567552665057466,18.85735868784695,0.6840418123785469,-0.5478435816657815,0.011937495102073455,0.06601796533722441,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.94388366560697,22.155690366356602,0.8882213637367635,-0.17100882307972587,0.1011575517621524,0.22649439984630318,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7435181209715,20.33303144334685,0.7602975551448584,-0.395363943018365,0.03233890622535644,0.12776133943709425,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9420229797029,19.92492725956015,0.9514327855943753,-0.07182635464117247,0.5371281770891978,0.6143830204984817,Downregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.650494824991533,25.6205543831508,1.1833703843838508,0.24290169504829842,0.24664902827947913,0.37201196414053667,Upregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.9043444632095,24.64122529176975,1.0308262303404454,0.04380115350595019,0.007344222661264532,0.047868594131456325,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.73681318211967,24.645134871652253,1.0382663705765187,0.054176619235249183,0.0689233230681695,0.18478426306978604,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8286430864367,24.796745268764198,1.0406276672496952,0.05745396998375725,0.13049515268200296,0.260277217097984,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.790375337821633,24.44420733103315,1.0274830465651403,0.039114589684884925,0.1689972872769079,0.29897850712402574,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.977628491503502,23.7074500957178,1.031762268437936,0.045110593188018376,0.07759098731260941,0.19667159978543358,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5077301332603,24.3704134130587,1.0366978553398407,0.05199548323659284,0.12008764569907131,0.24610504155004523,Upregulated
